281 related articles for article (PubMed ID: 28952258)
1. [Anti-tumor target prediction and activity verification of Ganoderma lucidum triterpenoids].
Du GH; Wang HX; Yan Z; Liu LY; Chen RY
Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(3):517-522. PubMed ID: 28952258
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease.
Bharadwaj S; Lee KE; Dwivedi VD; Yadava U; Panwar A; Lucas SJ; Pandey A; Kang SG
Sci Rep; 2019 Dec; 9(1):19059. PubMed ID: 31836806
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice.
Zhao RL; He YM
J Ethnopharmacol; 2018 Jan; 210():287-295. PubMed ID: 28882624
[TBL] [Abstract][Full Text] [Related]
4. Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y.
Liang C; Tian D; Liu Y; Li H; Zhu J; Li M; Xin M; Xia J
Eur J Med Chem; 2019 Jul; 174():130-141. PubMed ID: 31035236
[TBL] [Abstract][Full Text] [Related]
5. Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH.
Lin YX; Sun JT; Liao ZZ; Sun Y; Tian XG; Jin LL; Wang C; Leng AJ; Zhou J; Li DW
Fitoterapia; 2022 Apr; 158():105161. PubMed ID: 35217118
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships.
Chen S; Li X; Yong T; Wang Z; Su J; Jiao C; Xie Y; Yang BB
Oncotarget; 2017 Feb; 8(6):10071-10084. PubMed ID: 28052025
[TBL] [Abstract][Full Text] [Related]
7. Triterpenoids from Ganoderma lucidum and their cytotoxic activities.
Li P; Deng YP; Wei XX; Xu JH
Nat Prod Res; 2013; 27(1):17-22. PubMed ID: 22263904
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells.
Li P; Liu L; Huang S; Zhang Y; Xu J; Zhang Z
Anticancer Agents Med Chem; 2020; 20(2):237-244. PubMed ID: 31749435
[TBL] [Abstract][Full Text] [Related]
9. Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection.
Zhang W; Tao J; Yang X; Yang Z; Zhang L; Liu H; Wu K; Wu J
Biochem Biophys Res Commun; 2014 Jul; 449(3):307-12. PubMed ID: 24845570
[TBL] [Abstract][Full Text] [Related]
10. [Extraction of triterpenoids from fruiting [corrected] bodies of Ganoderma lucidum by supercritical fluid extraction].
Song SH; Jia XB; Chen Y; Chen B; Wang LJ; Zhao CL
Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(17):2104-7. PubMed ID: 19066051
[TBL] [Abstract][Full Text] [Related]
11. [Ganoderma triterpenoids from aqueous extract of Ganoderma lucidum].
Che XQ; Li SP; Zhao J
Zhongguo Zhong Yao Za Zhi; 2017 May; 42(10):1908-1915. PubMed ID: 29090550
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective Effects and Mechanisms of Action of Triterpenoids from Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) on α-Amanitin-Induced Liver Injury in Mice.
Wu H; Tang S; Huang Z; Zhou Q; Zhang P; Chen Z
Int J Med Mushrooms; 2016; 18(9):841-850. PubMed ID: 27910775
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant Properties of Triterpenoids Isolated from Bagasse-Cultivated Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), at Different Developmental Stages.
Huang Q; Wang L; Zhang L; Hu B; Wang Q; Liang L
Int J Med Mushrooms; 2022; 24(7):41-51. PubMed ID: 35993960
[TBL] [Abstract][Full Text] [Related]
14. New triterpenoids from the fruiting bodies of Ganoderma lucidum and their bioactivities.
Liu DZ; Zhu YQ; Li XF; Shan WG; Gao PF
Chem Biodivers; 2014 Jun; 11(6):982-6. PubMed ID: 24934684
[TBL] [Abstract][Full Text] [Related]
15. Identification and Quantification of Triterpenoids in Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), with HPLC-MS/MS Methods.
Xin H; Fang L; Xie J; Qi W; Niu Y; Yang F; Cai D; Zhang Y; Wen Z
Int J Med Mushrooms; 2018; 20(10):919-934. PubMed ID: 30806265
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro.
Yue GG; Fung KP; Tse GM; Leung PC; Lau CB
J Altern Complement Med; 2006 Oct; 12(8):777-89. PubMed ID: 17034284
[TBL] [Abstract][Full Text] [Related]
17. Triterpenoids with neurotrophic activity from Ganoderma lucidum.
Zhang XQ; Ip FC; Zhang DM; Chen LX; Zhang W; Li YL; Ip NY; Ye WC
Nat Prod Res; 2011 Oct; 25(17):1607-13. PubMed ID: 21671206
[TBL] [Abstract][Full Text] [Related]
18. Efficient Accumulation and In Vitro Antitumor Activities of Triterpene Acids from Submerged Batch--Cultured Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes).
Wang XL; Ding ZY; Zhao Y; Liu GQ; Zhou GY
Int J Med Mushrooms; 2017; 19(5):419-431. PubMed ID: 28845771
[TBL] [Abstract][Full Text] [Related]
19. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity.
Seo HW; Hung TM; Na M; Jung HJ; Kim JC; Choi JS; Kim JH; Lee HK; Lee I; Bae K; Hattori M; Min BS
Arch Pharm Res; 2009 Nov; 32(11):1573-9. PubMed ID: 20091270
[TBL] [Abstract][Full Text] [Related]
20. Distinct Responses of Cytotoxic Ganoderma lucidum Triterpenoids in Human Carcinoma Cells.
Ruan W; Wei Y; Popovich DG
Phytother Res; 2015 Nov; 29(11):1744-52. PubMed ID: 26292672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
